ALZANE 5 mg/ml Solution for injection for dogs and cats
ALZANE 5 mg/ml Solution for injection for dogs and cats
Authorised
- Atipamezole hydrochloride
Product identification
Medicine name:
ALZANE 5 mg/ml Solution for injection for dogs and cats
Alzane vet 5 mg/ml Injektionsvätska, lösning
Active substance:
- Atipamezole hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Atipamezole hydrochloride5.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QV03AB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Package description:
- box containing 10 vials of 10 ml
- box containing 5 vials of 10 ml
- box containing 1 vial of 10 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Syva S.A.
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 42704
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0147/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 6/04/2023
Swedish (PDF)
Published on: 27/05/2025
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025